Lion Biotechnologies, Inc. — Form D

Lion Biotechnologies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2011-05-03. The offering totals $1.0M, of which $500K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Jay VenkatesanDirectorBoston, MA
Maria FardisDirectorSan Francisco, CA
Maria FardisExecutive OfficerSan Francisco, CA
Anthony CataldoDirectorBeverly Hills, CA
Anthony CataldoExecutive OfficerBeverly Hills, CA
Paul KesslerDirectorLos Angeles, CA
Sanford J HillsbergDirectorLos Angeles, CA
Molly C HendersonExecutive OfficerNew York, NY
Michael T LotzeExecutive OfficerNew York, NY
Merrill McPeakDirectorNew York, NY
Merrill McPeakExecutive OfficerNew York, NY
Steven A FischkoffExecutive OfficerNew York, NY
Wayne J RothbaumDirectorNew York, NY
Ryan J MaynardDirectorNew York, NY
Michael HandelmanDirectorBeverly Hills, CA
Michael HandelmanExecutive OfficerBeverly Hills, CA
Manish SinghDirectorFremont, CA
Manish SinghExecutive OfficerFremont, CA
Sanford HillsbergDirectorWOODLAND HILLS, CA
Mark J AhnDirectorPortland, OR
David VoytickyDirectorLos Angeles, CA
Merrill A McPeakDirectorKNOXVILLE, TN
Dr. L. Stephen ColesDirectorLOS ANGELES, CA
David A VoytickyDirectorLOS ANGELES, CA
Dr. William Stephen AndrewsDirectorLOS ANGELES, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2016-06-15D$100.0M$100.0M
2013-11-15D$23.3M$23.3M
2013-06-06D$1.4M$1.4M
2011-08-09D$5.0M$5.0M
2011-01-21D$640K$640K
2010-11-08D$250K$250K
2010-10-01D$500K$500K

More